New and Emerging Trabecular Meshwork Bypass Stents

Author:

Shalaby Wesam Shamseldin,Moster Marlene R, ,

Abstract

Minimally invasive glaucoma surgery procedures are newly developed surgical modalities for the management of glaucoma. Their target is to lower intraocular pressure with minimal eye trauma and fewer complications. The first-generation iStent® (Glaukos Corp, Laguna Hills, CA, USA) is the first minimally invasive glaucoma surgery device to be approved for the treatment of open-angle glaucoma. It allows aqueous humour to be drained directly from the anterior chamber to Schlemm’s canal, bypassing the trabecular meshwork, which is believed to be the main site of outflow resistance. The second-generation iStent inject® (Glaukos Corp, Laguna Hills, CA, USA) is a smaller implant that allows simultaneous implantation of two stents, which could theoretically result in lower intraocular pressure. The Hydrus® Microstent (Alcon, Geneva, Switzerland) is another trabecular implant that dilates and scaffolds Schlemm’s canal. This articles reviews publications about all trabecular meshwork bypass stents, comparing them in terms of their efficacy and safety.

Funder

This article is published under the Creative Commons Attribution Non-commercial License.

Publisher

Touch Medical Media, Ltd.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3